SPARC and neoplasm: As such, our study is the first that associates stromal SPARC with tumor progression and poor outcome in CRC based on both patient and in vitro data, which is well in line with recent reports from pancreatic, gastric and biliary cancer that all identify stromal SPARC as a predictor of worse survival [45,46,47].